GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » YoY EBITDA Growth

Suzhou Novoprotein Scientific Co (SHSE:688137) YoY EBITDA Growth : -554.84% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Novoprotein Scientific Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Suzhou Novoprotein Scientific Co's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -554.84%.

Suzhou Novoprotein Scientific Co's EBITDA per Share for the three months ended in Jun. 2024 was ¥-0.14.


Suzhou Novoprotein Scientific Co YoY EBITDA Growth Historical Data

The historical data trend for Suzhou Novoprotein Scientific Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Novoprotein Scientific Co YoY EBITDA Growth Chart

Suzhou Novoprotein Scientific Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial - - - -51.12 -80.23

Suzhou Novoprotein Scientific Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -95.82 -94.56 -408.33 -144.52 -554.84

Suzhou Novoprotein Scientific Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Suzhou Novoprotein Scientific Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.453-2.291)/ | 2.291 |
=-80.23 %

Suzhou Novoprotein Scientific Co's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.141-0.031)/ | 0.031 |
=-554.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Novoprotein Scientific Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Suzhou Novoprotein Scientific Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Novoprotein Scientific Co Business Description

Traded in Other Exchanges
N/A
Address
No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.

Suzhou Novoprotein Scientific Co Headlines

No Headlines